KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
8.96
-0.09 (-0.99%)
Nov 20, 2024, 4:00 PM EST - Market closed
KalVista Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '24 Jul 31, 2024 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 30, 2020 | 2019 - 2015 |
| Revenue | - | - | - | - | - | 12.69 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | - | -21.31% | Upgrade
|
| Cost of Revenue | 93.47 | 86.17 | 80.28 | 70.17 | 41.29 | 40.19 | Upgrade
|
| Gross Profit | -93.47 | -86.17 | -80.28 | -70.17 | -41.29 | -27.5 | Upgrade
|
| Selling, General & Admin | 62.09 | 54.28 | 30.6 | 26.45 | 16.64 | 13.03 | Upgrade
|
| Operating Expenses | 62.09 | 54.28 | 30.6 | 26.45 | 16.64 | 13.03 | Upgrade
|
| Operating Income | -155.57 | -140.45 | -110.87 | -96.61 | -57.92 | -40.53 | Upgrade
|
| Interest & Investment Income | 4.67 | 3.9 | 2.23 | 1.09 | 0.9 | 1.83 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.2 | 0.14 | 0.09 | -1.54 | 0.85 | -0.37 | Upgrade
|
| Other Non Operating Income (Expenses) | 7.61 | 8.44 | 15.78 | 15.3 | 9.93 | 9.53 | Upgrade
|
| EBT Excluding Unusual Items | -143.1 | -127.97 | -92.77 | -81.76 | -46.24 | -29.54 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1.33 | 1.33 | -0.14 | -0.58 | - | 0.3 | Upgrade
|
| Pretax Income | -141.77 | -126.64 | -92.91 | -82.34 | -46.24 | -29.24 | Upgrade
|
| Income Tax Expense | - | - | - | - | - | -0.12 | Upgrade
|
| Net Income | -141.77 | -126.64 | -92.91 | -82.34 | -46.24 | -29.12 | Upgrade
|
| Net Income to Common | -141.77 | -126.64 | -92.91 | -82.34 | -46.24 | -29.12 | Upgrade
|
| Shares Outstanding (Basic) | 40 | 37 | 28 | 24 | 19 | 18 | Upgrade
|
| Shares Outstanding (Diluted) | 40 | 37 | 28 | 24 | 19 | 18 | Upgrade
|
| Shares Change (YoY) | 30.92% | 31.89% | 13.97% | 28.17% | 7.58% | 17.69% | Upgrade
|
| EPS (Basic) | -3.57 | -3.44 | -3.33 | -3.36 | -2.42 | -1.64 | Upgrade
|
| EPS (Diluted) | -3.57 | -3.44 | -3.33 | -3.36 | -2.42 | -1.64 | Upgrade
|
| Free Cash Flow | -102.78 | -89.27 | -76.46 | -79.07 | -30.25 | -45.04 | Upgrade
|
| Free Cash Flow Per Share | -2.59 | -2.43 | -2.74 | -3.23 | -1.58 | -2.54 | Upgrade
|
| Gross Margin | - | - | - | - | - | -216.74% | Upgrade
|
| Operating Margin | - | - | - | - | - | -319.41% | Upgrade
|
| Profit Margin | - | - | - | - | - | -229.44% | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | - | -354.89% | Upgrade
|
| EBITDA | -154.72 | -139.63 | -110.15 | -96.05 | -57.39 | -40.02 | Upgrade
|
| D&A For EBITDA | 0.85 | 0.82 | 0.72 | 0.56 | 0.54 | 0.51 | Upgrade
|
| EBIT | -155.57 | -140.45 | -110.87 | -96.61 | -57.92 | -40.53 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.